Cargando…
SARS-CoV-2: tracing the origin, tracking the evolution
The origin of SARS-CoV-2 is uncertain. Findings support a “bat origin” but results are not highly convincing. Studies found evidence that SARS-CoV-2 was around for many years before the pandemic outbreak. Evidence has been published that the progenitor of SARS-CoV-2 already had the capability to bin...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931788/ https://www.ncbi.nlm.nih.gov/pubmed/35303887 http://dx.doi.org/10.1186/s12920-022-01208-w |
_version_ | 1784671336160821248 |
---|---|
author | Voskarides, Konstantinos |
author_facet | Voskarides, Konstantinos |
author_sort | Voskarides, Konstantinos |
collection | PubMed |
description | The origin of SARS-CoV-2 is uncertain. Findings support a “bat origin” but results are not highly convincing. Studies found evidence that SARS-CoV-2 was around for many years before the pandemic outbreak. Evidence has been published that the progenitor of SARS-CoV-2 already had the capability to bind strongly to the human ACE2 receptor. This may be an indication that many other animal viruses are capable to jump to humans, having already affinity for a human receptor. This is quite worrying since current ecosystems’ collapse brings people to high proximity with animals, increasing probabilities for random viral transitions. On the other hand, future adaptation of SARS-CoV-2 is of great concern. Virus-host interactions are complicated and unfortunately, we still do not have accurate tools for predicting viruses’ future evolution. Viral adaptation is a multifactorial process and probably SARS-CoV-2 will not become soon, as we wish, a harmless infection. However, humanity is currently under the largest vaccination program and it’s of great interest to see if vaccinations will change the evolutionary game against the virus. |
format | Online Article Text |
id | pubmed-8931788 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-89317882022-03-18 SARS-CoV-2: tracing the origin, tracking the evolution Voskarides, Konstantinos BMC Med Genomics Review The origin of SARS-CoV-2 is uncertain. Findings support a “bat origin” but results are not highly convincing. Studies found evidence that SARS-CoV-2 was around for many years before the pandemic outbreak. Evidence has been published that the progenitor of SARS-CoV-2 already had the capability to bind strongly to the human ACE2 receptor. This may be an indication that many other animal viruses are capable to jump to humans, having already affinity for a human receptor. This is quite worrying since current ecosystems’ collapse brings people to high proximity with animals, increasing probabilities for random viral transitions. On the other hand, future adaptation of SARS-CoV-2 is of great concern. Virus-host interactions are complicated and unfortunately, we still do not have accurate tools for predicting viruses’ future evolution. Viral adaptation is a multifactorial process and probably SARS-CoV-2 will not become soon, as we wish, a harmless infection. However, humanity is currently under the largest vaccination program and it’s of great interest to see if vaccinations will change the evolutionary game against the virus. BioMed Central 2022-03-18 /pmc/articles/PMC8931788/ /pubmed/35303887 http://dx.doi.org/10.1186/s12920-022-01208-w Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/ Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Review Voskarides, Konstantinos SARS-CoV-2: tracing the origin, tracking the evolution |
title | SARS-CoV-2: tracing the origin, tracking the evolution |
title_full | SARS-CoV-2: tracing the origin, tracking the evolution |
title_fullStr | SARS-CoV-2: tracing the origin, tracking the evolution |
title_full_unstemmed | SARS-CoV-2: tracing the origin, tracking the evolution |
title_short | SARS-CoV-2: tracing the origin, tracking the evolution |
title_sort | sars-cov-2: tracing the origin, tracking the evolution |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931788/ https://www.ncbi.nlm.nih.gov/pubmed/35303887 http://dx.doi.org/10.1186/s12920-022-01208-w |
work_keys_str_mv | AT voskarideskonstantinos sarscov2tracingtheorigintrackingtheevolution |